Metabolomics

Dataset Information

0

Metabolomics of human primary B-ALL cells treated by BCR-Abl1 inhibitor, STI571, and p190 BCR-Abl+ BAF3 cells with ASS1 knockdown


ABSTRACT: Analyze the Metabolomics changes in B-ALL cells after the treatment of imatinib and p190+ BAF3 cells with ASS1 knockdown or left untreated. two methods as the below LC-MS description showed were used.

INSTRUMENT(S): Liquid Chromatography MS - alternating - reverse-phase

PROVIDER: MTBLS14638 | MetaboLights | 2026-07-08

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
a_MTBLS14638_LC-MS_alternating_reverse-phase.txt Txt
i_Investigation.txt Txt
m_MTBLS14638_LC-MS_alternating_reverse-phase_v2_maf.tsv Tabular
s_MTBLS14638.txt Txt
Items per page:
1 - 4 of 4

Similar Datasets

2023-01-18 | GSE215107 | GEO
2017-01-14 | GSE93620 | GEO
2024-07-16 | PXD040109 | Pride
| EGAD00010002336 | EGA
2005-04-07 | GSE2504 | GEO
| PRJNA305862 | ENA
2018-06-11 | GSE104759 | GEO
| PRJNA414971 | ENA
2011-04-12 | GSE28552 | GEO
2024-01-17 | GSE217758 | GEO